William John Sibold

Insider Reports History

Entity
Individual
Location
C/O Madrigal Pharmaceuticals, Inc., Four, Tower Bridge, 200 Barr Harbor Dr Ste 200, West Conshohocken, PA
Signature
/s/ Mardi Dier, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William John Sibold:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. President and CEO, Director Common Stock 117K $40.5M $344.76 Mar 5, 2025 Direct
MADRIGAL PHARMACEUTICALS, INC. President and CEO, Director Performance Restricted Stock Units 0 $0 $348.94 Feb 27, 2025 Direct
MADRIGAL PHARMACEUTICALS, INC. President and CEO, Director Stock Option (Right to Buy) 22K Mar 5, 2025 Direct

Insider Reports Filed by William John Sibold

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MDGL MADRIGAL PHARMACEUTICALS, INC. Mar 5, 2025 2 $0 4 Mar 7, 2025 President and CEO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Feb 27, 2025 2 $0 4 Feb 28, 2025 President and CEO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 24, 2025 1 -$531K 4 Jan 27, 2025 President and CEO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Sep 9, 2024 1 -$1.55M 4 Sep 11, 2024 President and CEO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 23, 2024 3 $0 4 Jan 25, 2024 President and CEO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Sep 11, 2023 2 $0 4 Sep 13, 2023 President and CEO, Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Sep 8, 2023 0 $0 3 Sep 13, 2023 President and CEO, Director